About the Center

Why Focus on Cardiovascular Innovation?

Estimated at more than $420 billion, cardiovascular medicine is the largest healthcare market opportunity in the US. The cardiovascular disease burden poses clear challenges – medical, scientific, and commercial – with enormous benefit accruing to the investigators, entrepreneurs, and companies that can provide innovative, state-of-the-art solutions.

GCIC is building cross-industry partnerships to facilitate the development and adoption of new cardiovascular technologies geared towards improving patient care. Cardiovascular research and commercialization – along with millions of patients – will benefit from the progress made through companies affiliated with GCIC.